Emoritcha, Jasmir S.
HRN: 09-02-98 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/10/2023
12/16/2023
IV
500mg
Q8
Amoebiasis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes